211265
4-Phenoxybenzaldehyde
98%
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Linear Formula:
C6H5OC6H4CHO
CAS Number:
Molecular Weight:
198.22
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
200-650-7
Beilstein/REAXYS Number:
1947841
MDL number:
Assay:
98%
InChI key
QWLHJVDRPZNVBS-UHFFFAOYSA-N
InChI
1S/C13H10O2/c14-10-11-6-8-13(9-7-11)15-12-4-2-1-3-5-12/h1-10H
SMILES string
O=Cc1ccc(Oc2ccccc2)cc1
assay
98%
refractive index
n20/D 1.611 (lit.)
bp
185 °C/14 mmHg (lit.)
mp
24-25 °C (lit.)
density
1.132 g/mL at 25 °C (lit.)
functional group
aldehyde, phenoxy
Quality Level
Related Categories
Application
4-Phenoxybenzaldehyde was used in the synthesis of:
- spirodiketopiperazine derivatives
- benzoxazoles
Storage Class
10 - Combustible liquids
wgk
WGK 3
flash_point_f
230.0 °F - closed cup
flash_point_c
110 °C - closed cup
ppe
Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite.
Rena Nishizawa et al.
Bioorganic & medicinal chemistry letters, 17(3), 727-731 (2006-11-23)
Hydroxylated derivatives were designed and synthesized based on the information of oxidative metabolites. Compounds derived from beta-substituted (2R,3R)-2-amino-3-hydroxypropionic acid showed improved inhibitory activities against the binding of MIP-1alpha to human CCR5, compared with the non-hydroxylated derivatives and the other isomers.
Kelly J McClure et al.
Bioorganic & medicinal chemistry letters, 16(7), 1924-1928 (2006-01-31)
In a recent paper, [Arienti, K. L.; Brunmark, A.; Axe, F. U.; McClure, K. M.; Lee, A.; Blevitt, J.; Neff, D. K.; Huang, L.; Crawford, S.; Chennagiri, R. P.; Karlsson, L.; Brietenbucher, J. G. J. Med. Chem.2005, 48, 1873], we
Vikas N Telvekar et al.
Bioorganic & medicinal chemistry letters, 22(1), 649-652 (2011-11-15)
A series of structurally novel, substituted 2-(2-(4-aryloxybenzylidene) hydrazinyl)benzothiazole derivatives incorporating 2-hydrazinyl benzothiazole and 4-(aryloxy)benzaldehyde were designed and synthesized using molecular hybridization approach. All the synthesized compounds exhibited promising activity (MIC 1.5-29.00μg/ml) against Mycobacteriumtuberculosis H37Rv strains of using REMA. Five of
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service